Category: Hematology & Oncology
Oceania Hematology & Oncology
-
2023 New Zealand Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... other published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2023 Australia Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
MEA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and ... Read More
-
Femtech Market Size By Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Femtech Market is ... Read More
-
Immuno-Oncology Assays Market, By Product (Consumables and Software), By Technology (Immunoassay, PCR, NGS, Flow Cytometry, and Others), By Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, and Others), By Application (Clinical Diagnostics and Research and Development), and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Development), and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immuno-oncology is emerging as a novel approach to cancer treatment through ... Read More
-
Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), Application (Cardiology, Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Technology (Radio immunoassay (RIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)
... Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions ... Read More
-
Australia In-vitro Diagnostics Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... COVID, the country's conditions were under control. The administration kept its limitations on travel in place. The Australian Health Protection Principal Committee (AHPPC) highly advised wearing masks indoors, especially in situations where physical separation is ... Read More
-
In Vitro Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity ... Read More
-
Oncology Drugs Market, by Drug Type (Cytotoxic Drugs (Alkylating Agents, Antimetabolites, and Others), Targeted Drugs (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), and Hormonal Drugs (Ovarian Function Blockers, Estrogen Production Blockers, and Estrogen’s Effect Blockers (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Screening Tests), By End User (Hospitals Independent Diagnostic Labs and Other End Users), and By Geography (North America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Colorectal cancer is a type of cancer that begins in the large intestine (colon). The ... Read More
-
Molecular Diagnostics Market, by Product Type (Reagents & Kits and Instruments), by Application (Oncology, Genetic Testing, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, and Others), by End User (Hospitals, Diagnostic Laboratories, Academic and Research Labs, and Other), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Research Labs, and Other), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Molecular diagnostics is used for detection in various ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
Asia-Pacific Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Asia Pacific Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)
... Hospitals and Clinics, Specialty Clinics, and Home Care Services) The Asia Pacific (APAC) cervical cancer diagnostic testing market is expected to grow from US$ 936.22 million in 2021 to US$ 1,351.28 million by 2028. It ... Read More
-
U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Product Type (Reagents and Kits & Instruments), by Technology (PCR-based (Liquid Biopsy Testing, Tissue Testing) and NGS-based (Liquid Biopsy Testing, Tissue Testing)), by Application, (Genetic Testing, Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
Research Assistance
